首页> 外国专利> New compounds hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone

New compounds hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone

机译:新化合物六氢环戊吡咯烷酮,六氢吡咯并吡咯烷酮,八氢吡咯并吡啶酮和八氢吡啶并酮

摘要

Compounds of formula (I): ** Formula ** R1 is alkyl, haloalkyl, alkoxyalkyl, haloalkoxyalkyl, hydroxyalkyl, phenyl, substituted phenyl, phenylalkyl, substituted phenylalkyl, phenoxyalkyl, phenoxyalkyl, heteroaryl, substituted heteroaryl, heteroaryl, alkyl or heteroaryl, heteroaryl, alkyl wherein substituted phenyl, substituted phenylalkyl, substituted phenoxyalkyl, substituted heteroaryl and substituted heteroarylalkyl is substituted with one to three substituents independently selected from alkyl, cycloalkyl, cycloalkylalkyl, halo, haloalkyl, hydroxy, hydroxyalkyl, alkoxy, alkoxyalkyl, haloalkoxy, hydroxyhaloalkyl and alcoxihaloalquilo , R2 is phenyl, substituted phenyl, heteroaryl or substituted heteroaryl, in which substituted phenyl and substituted heteroaryl are substituted with one to three substituents independently selected from alkyl, cycloalkyl, cycloalkylalkyl, halogen, haloalkyl, hydroxy, hydroxyalkyl, alkoxy, alkoxyalkyl, haloalkoxy, hydroxyhaloalkyl and alkoxyhaloalkyl, R3 is hydrogen, hydroxy or alkoxy, where, in the case where R3 is hydroxy or alkoxy, E is -C (R5R6) -, R4 is hydrogen, alkyl or cycloalkyl, R5 is hydrogen, alkyl or cycloalkyl, R6 is hydrogen, alkyl or cycloalkyl, n is 1 or 2; A is -N or -CR3; E is a bond or -C (R5R6) -, G is -O-, -NR4-, -CH (OH) -, -C (O) -, -C (O) O-, -C (O) NR4 -, -S (O) 2-, -S (O) 2NR4- or a bond, in which, in case E and G are a bond, R1 is directly linked to A, or pharmaceutically acceptable salts of thereof, in which: the term "alkyl" refers to a monovalent linear or branched saturated hydrocarbon group with 1 to 7 carbon atoms, the term "cycloalkyl" refers to a monovalent saturated monocyclic or bicyclic hydrocarbon group with 3 to 10 ring carbon atoms, the term "heteroaryl" refers to a monovalent aromatic mono- or bi-cyclic ring system with 5 to 12 ring atoms, comprising 1, 2, 3 or 4 heteroatoms selected from N, O and S, the remaining ring atoms being carbon.
机译:式(I)的化合物:**式** R 1为烷基,卤代烷基,烷氧基烷基,卤代烷氧基烷基,羟烷基,苯基,取代的苯基,苯基烷基,取代的苯基烷基,苯氧基烷基,苯氧基烷基,杂芳基,取代的杂芳基,杂芳基,烷基或杂芳基,杂芳基烷基,其中取代的苯基,取代的苯基烷基,取代的苯氧基烷基,取代的杂芳基和取代的杂芳基烷基被1-3个独立地选自烷基,环烷基,环烷基烷基,卤素,卤代烷基,羟基,羟烷基,烷氧基,烷氧基烷基,卤代烷氧基,羟基卤代烷基和烷氧基卤代烷基的取代基取代R2是苯基,取代的苯基,杂芳基或取代的杂芳基,其中取代的苯基和取代的杂芳基被1-3个独立地选自烷基,环烷基,环烷基烷基,卤素,卤代烷基,羟基,羟烷基,烷氧基,烷氧基烷基,卤代烷氧基的取代基取代,羟基卤代烷基和烷氧基卤代烷基3为氢,羟基或烷氧基,其中,当R3为羟基或烷氧基时,E为-C(R5R6)-,R4为氢,烷基或环烷基,R5为氢,烷基或环烷基,R6为氢,烷基或环烷基,n为1或2; A为-N或-CR3; E是一个键或-C(R5R6)-,G是-O-,-NR4-,-CH(OH)-,-C(O)-,-C(O)O-,-C(O)NR4 -,-S(O)2,-S(O)2NR4-或其中E和G为键的情况下,R1直接与A或其可药用盐连接的键或其药学上可接受的盐,其中:术语“烷基”是指具有1至7个碳原子的单价直链或支链饱和烃基,术语“环烷基”是指具有3至10个环碳原子的单价饱和单环或双环烃基,术语“杂芳基”术语“单环芳族环系统”是指具有5至12个环原子的单价芳族单环或双环系统,其包含1、2、3或4个选自N,O和S的杂原子,其余的环原子为碳。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号